Gandhi Medicos Logo
Back to compositions index
Active Chemical Molecule

Dolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate

Dolutegravir -50mg

Lamivudine -300mg

Tenofovir disoproxil fumarate -300mg

Classification - HIV Medicine

Why are dolutegravir, lamivudine, and tenofovir disoproxil fumarate combined into a single tablet?

The combination makes administration easier.

It also offers synergistic effects to suppress HIV.

Uses of Dolutegravir, lamivudine, and tenofovir disoproxil fumarate tablet-

It is used in HIV infections.

Dolutegravir, lamivudine, and tenofovir disoproxil fumarate working-

It blocks viral replication at multiple stages.

Dolutegravir- It prevents genetic changes in human cells.

Lamivudine - It inhibits the formation of viral DNA in cells.

Tenofovir - It inhibits viral cell multiplication.

The benefits of using dolutegravir, lamivudine, and tenofovir disoproxil fumarate tablet -

Powerful control of HIV

Well tolerated,

Lowers the risk of drug resistance

Fewer side-effects

Improves immunity

Prevent transmission

Prevents HIV progression

What are the side effects?

Common side effects

Insomnia

Tiredness

Headache

Increased weight

Skin rashes

Abdominal pain

Nausea

Diarrhea

Hyperlipidemia

Serious side effects

Liver dysfunction

Lactic acidosis

Increased blood glucose

Kidney dysfunctions

Neurological side effects - depression / suicidal thoughts

Bone density loss

Dolutegravir, lamivudine, and tenofovir disoproxil fumarate tablet precautions -

Do not stop medication immediately.

As it may flare up the previous hepatitis infection.

Use it carefully in -

Diabetes

Liver disorders

Mental health

Elderly

Kidney impairment

Pregnant women

Dolutegravir, lamivudine, and tenofovir disoproxil fumarate tablet drug interactions-

It must be completely avoided with Dofetilide.

It must be carefully used with -

Antacids

Rifampicin

Phenytoin

Barbiturates

Metformin

Supplements containing Iron or calcium

What are dolutegravir, lamivudine, and tenofovir disoproxil fumarate tablet warnings?

To be used under medical prescription.

It must be avoided in -

Severe liver dysfunction

Severe renal impairment

Hypersensitivity or allergy to drug components.

Breastfeeding mothers

Co-administration with nephrotoxic drugs

Important Monitoring Considerations -

Long-term use of dolutegravir, lamivudine, and tenofovir disoproxil fumarate tablet must be checked for -

Liver function - elevated liver enzymes

Viral loads (HIV, HBV)

Bone loss

Neurological conditions

Renal functions

Blood glucose

Weight

CD4+ count

Gandhi Medicos: 19 years of legacy in HIV care

Gandhi Medicos is the leading HIV medicine distributor and supplier to hospitals, HIV care centers, NGOs, and pharmacies worldwide.

✅ 400+ Ethical Brands

✅ 500+ Generic Options

✅ Leading Exporter of Fixed-Dose HIV Combinations

✅ 25,000 + Happy Customers

✅ 3,000+ Monthly Orders

Why Choose Gandhi Medicos?

🔹 WHO-GMP Certified Products

🔹 Delivering to 50+ Countries

🔹 Temperature-Controlled Shipping

🔹 Prompt Customer Response

🔹 Reliable, On-Time Deliveries

Gandhi Medicos - Trusted HIV Medicines

Frequently Asked Questions about Dolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate

It affects bone remodeling. It leads to breakdown of the bone.

Referral & Authority Resources for Dolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate

Formulations based on "Dolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate" (3)

Cipanec Tablet
HIVVerified Supply

Cipanec Tablet

Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg)

Product Name  Cipanec Tablet Composition Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) Dose/Strength  50mg+300mg+300mg Form Tablet Manufactured By                     Cipla Packaging Size 30 tablets in 1 Bottel Prescription Required Storage Store below 30°C

Specialty BrandCipla
Unit DosageTablet (50mg+300mg+300mg)
Clinical SourceCipla
Temp Tracked: Store below 30°C
Inspect
ACRIPTEGA TABLET
HIVVerified Supply

ACRIPTEGA TABLET

Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg)

Product Name  ACRIPTEGA TABLET Composition  Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) Dose/Strength  50mg+300mg+300mg Form  Tablet Manufactured By                  Mylan Pharmaceuticals Pvt Ltd Packaging Size 30 tablets in 1 bottel Prescription  Required Storage Store below 30°C

Specialty BrandMylan
Unit DosageTablet (50mg+300mg+300mg)
Clinical SourceMylan
Temp Tracked: Store below 30°C
Inspect
Viropil
HIVVerified Supply

Viropil

Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg)

Product Name  Viropil Composition Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) Manufactured By Emcure Pharmaceuticals Ltd Dose/Strength 50 mg/ 300mg/ 300mg Packaging Size 30 Tablets Prescription Required Storage Store below 30°C

Specialty BrandEmcure
Unit DosageTablet (50 mg/ 300mg/ 300mg)
Clinical SourceEmcure
Temp Tracked: Store below 30°C
Inspect

Important Medical Disclaimer & Legal Notices

Medical Disclaimer: All content found on the Gandhi Medicos Website, including: text, images, audio, or other formats were created for informational purposes only. Offerings for continuing education credits are clearly identified and the appropriate target audience is identified. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.

Gandhi Medicos - Exporters of Generic Medicines. If you think you may have a medical emergency, call your doctor or go to the emergency department, or immediately. Gandhi Medicos does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on Gandhi Medicos. Reliance on any information provided by Gandhi Medicos, Gandhi Medicos employees, contracted writers, or medical professionals presenting content for publication to Gandhi Medicos is solely at your own risk.

The Site may contain health- or medical-related materials or discussions regarding sexually explicit disease states. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an “as is” basis. Gandhi Medicos - Exporters of Generic Medicines. Links to educational content not created by Gandhi Medicos are taken at your own risk. Gandhi Medicos is not responsible for the claims of external websites and education companies.

General Advisory: We advise you to stick to medication routine (or medication adherence), i.e. to take medications as prescribed – the right dose, at the right time, in the right way and frequency. Not taking medicines as prescribed by a doctor or instructed by a pharmacist could lead to disease getting worse, hospitalization, even death.

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer's risk.

All Trademarks, Brands and Service marks that appear on this website belong to their respective owner.